Healthcare Payers

Challenges of Improving Access to Digital Therapeutics in Healthcare

December 20, 2022 - In an increasingly digital landscape, digital therapeutics (DTx) are quickly transforming the healthcare industry. Still, developers of DTx face numerous challenges, such as encouraging adoption, proving clinical efficacy, and ensuring product reimbursement. What Are the Benefits of Digital Therapeutics? Using evidence-based and clinically evaluated software, digital therapeutics...

Read More


More Articles

Biosimilars Have Saved $12.6 Billion in the US between 2014 and 2022

by Veronica Salib

Biosimilars are gaining new traction in the pharmaceutical industry as a tool for providers and patients to manage diseases. The National Cancer Institute defines a biosimilar drug as a “biological drug that is very much like another...

Abbott, Walgreens Increase Rapid COVID-19 Testing in Pennsylvania

by Samantha McGrail

Abbott and Walgreens recently launched a pilot program to increase access to rapid COVID-19 testing for Pennsylvania Electronic Benefit Transfer (EBT) cardholders in the city of Philadelphia. Under...

Prescription Drug Costs Increased 3X Over the Past Decade

by Samantha McGrail

The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy...

Former Pharma Executive Pleads Guilty to Antitrust Conspiracy

by Samantha McGrail

The Department of Justice announced that a former generic pharmaceutical executive pled guilty last week for his role in criminal antitrust conspiracy from March 2013 to June 2015. According to court...

Recent Articles